|
TMEM68 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.393000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.963300E-04 |
| Normal-vs-Stage2 |
2.431200E-01 |
| Normal-vs-Stage3 |
1.354310E-02 |
| Normal-vs-Stage4 |
5.668500E-02 |
| Stage1-vs-Stage2 |
1.029780E-01 |
| Stage1-vs-Stage3 |
4.379200E-01 |
| Stage1-vs-Stage4 |
3.723600E-01 |
| Stage2-vs-Stage3 |
3.400600E-01 |
| Stage2-vs-Stage4 |
5.138400E-01 |
| Stage3-vs-Stage4 |
7.896400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.155650E-03 |
| Normal-vs-AfricanAmerican |
3.367700E-02 |
| Normal-vs-Asian |
5.782500E-03 |
| Caucasian-vs-AfricanAmerican |
8.694600E-01 |
| Caucasian-vs-Asian |
6.821600E-01 |
| AfricanAmerican-vs-Asian |
8.957200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.343700E-02 |
| Normal-vs-Female |
2.781600E-04 |
| Male-vs-Female |
1.044640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.214300000009E-05 |
| Normal-vs-Age(41-60Yrs) |
1.145930E-02 |
| Normal-vs-Age(61-80Yrs) |
3.806300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.413000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.847700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.031900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.385000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.864600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.487600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.973200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.321200E-01 |
| Classical-VS-Follicular |
3.002000E-03 |
| Classical-VS-Other |
6.271200E-01 |
| Classical-VS-Normal |
9.5152999999959E-05 |
| Tall-VS-Follicular |
1.287820E-02 |
| Tall-VS-Other |
3.601000E-01 |
| Tall-VS-Normal |
7.182600E-04 |
| Follicular-VS-Other |
6.174000E-01 |
| Follicular-VS-Normal |
3.547600E-01 |
| Other-VS-Normal |
2.792200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.824100E-02 |
| Normal-vs-N1 |
2.162000E-02 |
| N0-vs-N1 |
3.944400E-01 |
|
|
